Genotypic and functional roles of IL-1B and IL-1RN on the risk of gastroesophageal reflux disease: The presence of IL-1B-511*T/IL- 1RN*1 (T1) haplotype may protect against the disease

American Journal of Gastroenterology

Volumn 104, Issue 11, 2009, Pages 2704-2713

  Chourasia, Dipti ^a   Achyut, B R ^a   Tripathi, Shweta ^a   Mittal, Balraj ^a   Mittal, Rama D ^a   Ghoshal, Uday C ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; OMEPRAZOLE;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; ENDOSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGITIS; ESOPHAGUS PH; FEMALE; GASTROESOPHAGEAL REFLUX; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK; RISK REDUCTION; SCORING SYSTEM; STOMACH MUCOSA;

ADULT; BIOPSY, NEEDLE; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESOPHAGOSCOPY; FEMALE; FOLLOW-UP STUDIES; GASTROESOPHAGEAL REFLUX; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; MINISATELLITE REPEATS; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROBABILITY; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 72049101630     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.382     Document Type: Article

References (24)

1. Holtmann G, Adam B, Liebregts T. Review article: the patient with gastro-oesophageal reflux disease-lifestyle advice and medication. Aliment Pharmacol Th er 2004;20 (Suppl 8):24-27 (Pubitemid 39657662)
2. Terry P, Lagergren J, Wolk A et al. Reflux-inducing dietary factors and risk of adenocarcinoma of the esophagus and gastric cardia. Nutr Cancer 2000;38:186-191 (Pubitemid 32762018)
3. Chourasia D, Ghoshal UC. Pathogenesis of gastro-oesophageal reflux disease: what role do Helicobacter pylori and host genetic factors play? Trop Gastroenterol 2008;29:13-19
4. de Vries DR, ter Linde JJ, van Herwaarden MA et al. Gastroesophageal reflux disease is associated with the C825T polymorphism in the G-protein beta3 subunit gene (GNB3). Am J Gastroenterol 2009;104:281-285
5. Cameron AJ, Lagergren J, Henriksson C et al. Gastroesophageal reflux disease in monozygotic and dizygotic twins. Gastroenterology 2002;122:55-59 (Pubitemid 34049194)
6. Mohammed I, Cherkas LF, Riley SA et al. Genetic influences in gastrooesophageal reflux disease: a twin study. Gut 2003;52:1085-1089 (Pubitemid 36877417)
7. Camargo MC, Mera R, Correa P et al. Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006;15:1674-1687 (Pubitemid 44497104)
8. Mattuzzi S, Barbi S, Carletto A et al. Association of polymorphisms in the IL1B and IL2 genes with susceptibility and severity of systemic sclerosis. J Rheumatol 2007;34:997-1004. (Pubitemid 46774845)
9. Furuta T, El-Omar EM, Xiao F et al. Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 2002 ; 123:92-105. (Pubitemid 34747529)
10. Ruzzo A, Graziano F, Pizzagalli F et al. Interleukin 1B gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in Helicobacter pylori-negative gastric cancer of intestinal and diffuse histotype. Ann Oncol 2005;16:887-892 (Pubitemid 40903913)
11. Danis VA, Millington M, Hyland VJ et al. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 1995;99:303-310
12. Queiroz DM, Guerra JB, Rocha GA et al. IL1B and IL1RN polymorphic genes and Helicobacter pylori cagA strains decrease the risk of reflux esophagitis. Gastroenterology 2004;127:73-79 (Pubitemid 38962276)
13. Ando T, El-Omar EM, Goto Y et al. Interleukin 1B proinflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy. Gut 2006;55:158-164 (Pubitemid 43117270)
14. Bowrey DJ, Williams GT, Clark GW. Histological changes in the oesophageal squamous mucosa: correlation with ambulatory 24 hour pH monitoring . J Clin Pathol 2003;56:205-208
15. Ghoshal UC, Chourasia D, Tripathi S et al. Relationship of severity of gastroesophageal reflux disease with gastric acid secretory profile and esophageal acid exposure during nocturnal acid breakthrough: a study using 24-h dual-channel pH-metry. Scand J Gastroenterol 2008;43:654-661 (Pubitemid 351868703)
16. Lundell LR, Dent J, Bennett JR et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45:172-180 (Pubitemid 29333764)
17. Rad R, Prinz C, Neu B et al. Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. J Infect Dis 2003;188:272-281 (Pubitemid 36898160)
18. Tarlow JK, Blakemore AI, Lennard A et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993;91:403-404 (Pubitemid 23177503)
19. Hacker UT, Erhardt S, Tschop K et al. Influence of the IL-1Ra gene polymorphism on in vivo synthesis of IL-1Ra and IL-1beta aft er live yellow fever vaccination. Clin Exp Immunol 2001;125:465-469 (Pubitemid 34155444)
20. Hurme M, Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes. Eur J Immunol 1998;28:2598-2602 (Pubitemid 28362734)
21. Vamvakopoulos J, Green C, Metcalfe S. Genetic control of IL-1beta bioactivity through differential regulation of the IL-1 receptor antagonist. Eur J Immunol 2002;32:2988-2996 (Pubitemid 35238192)
22. Upadhyay R, Jain M, Kumar S et al. Potential influence of interleukin-1 haplotype IL-1 beta-511*T-IL-1RN*1 in conferring low risk to middle third location of esophageal cancer: a case-control study. Hum Immunol 2008;69:179-186
23. Achyut BR, Moorchung N, Mittal B. Genetic association of interleukin-1 haplotypes with gastritis and precancerous lesions in North Indians. Clin Exp Med 2008;8:23-29 (Pubitemid 351666848)
24. Singh H, Sachan R, Goel H et al. Genetic variants of interleukin-1RN and interleukin-1beta genes and risk of cervical cancer. BJOG 2008;115:633-638 (Pubitemid 351357571)